H1N1 influenza – Page 4 – Communicable Diseases Research

Next-Generation Molecular Diagnostics Development by CRISPR/Cas Tool: Rapid Detection and Surveillance of Viral Disease Outbreaks

Molecular Biosciences

Published on 2020-12-232022-10-31
Journal: Frontiers in Molecular Biosciences [Category] COVID-19,

COVID-19 Symptom-Related Google Searches and Local COVID-19 Incidence in Spain: Correlational Study

Original Paper

Published on 2020-12-182022-10-30
Journal: Journal of Medical Internet Research [Category] COVID-19, MERS,

Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives

Review

Published on 2020-12-152022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, SARS, 신종인플루엔자,

Seasonality and immunity to laboratory-confirmed seasonal coronaviruses (HCoV-NL63, HCoV-OC43, and HCoV-229E): results from the Flu Watch cohort study

Research Article

Published on 2020-12-102022-10-28
Journal: Wellcome Open Research [Category] COVID-19,

Mental health of clinical staff working in high-risk epidemic and pandemic health emergencies a rapid review of the evidence and living meta-analysis

Review

Published on 2020-11-272022-10-28
Journal: Social psychiatry and psychiatric epidemiology [Category] COVID-19, MERS, SARS, 신종인플루엔자,

Regeneration of the pulmonary vascular endothelium after viral pneumonia requires COUP-TF2

Research Article

Published on 2020-11-252022-10-28
Journal: Science Advances [Category] COVID-19, Fulltext, 신종인플루엔자,

[키워드] Ablation Activation Angiogenesis blood vessel Critical cyclin D1 dependent on developmental distress endothelial Endothelial cell endothelial repair Endothelium ENhance exacerbating Gas exchange greater H1N1 influenza impairing implicated in vivo Inflammatory response Influenza Injury Lineage lung Lung injury mechanisms Migration Mortality nuclear ovalbumin Pathogens proliferation reduced regeneration regenerative regulate repair reveal robust SARS-CoV-2 suppresse syndrome therapeutic strategy therapeutic targeting transcription factor upstream Vascular Vascular endothelium vascular homeostasis Viral pneumonia while
[DOI] 10.1126/sciadv.abc4493 PMC 바로가기 [Article Type] Research Article

NLRP3 Inflammasome: The Stormy Link Between Obesity and COVID-19

NLRP3 Inflammasome: 비만과 COVID-19 사이의 폭풍우 연결

Review

Published on 2020-10-302022-09-11
Journal: Frontiers in Immunology [Category] MERS, SARS, 유전자 메커니즘,

[키워드] accelerate Activation addition Cancer cause Cell cell death coronavirus disease Coronavirus disease 2019 country COVID-19 cytokine Cytokine release syndrome Cytokine storm Cytokines death diabetes disease dyslipidemia H1N1 H1N1 influenza HIV hypertension hypertriglyceridemia immune response individual induce infections Inflammasome Influenza leads metabolic syndrome molecular mechanism molecular mechanisms multifactorial multiorgan failure multiple comorbidities multiple comorbidity NLRP3 NLRP3 inflammasome obesity obesogenic Osteoarthritis pandemic pro-inflammatory cytokine pro-inflammatory cytokines provide pyroptosis responsible SARS-CoV-2 SARS-COV-2 infection secretion severe acute respiratory syndrome coronavirus 2 syndrome systemic inflammation systemic inflammatory triggering type 2 diabetes virus viruses
[DOI] 10.3389/fimmu.2020.570251 PMC 바로가기 [Article Type] Review

The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation

COVID-19의 깔끔한 춤: NEAT1, DANCR 및 공동 조절 콜린성 RNA가 염증과 연결

Immunology

Published on 2020-10-092022-09-11
Journal: Frontiers in Immunology [Category] MERS, SARS, 신종인플루엔자, 유전자 메커니즘,

[키워드] Accompanying ACE2 Acetylcholine acetylcholine signaling age Analysis association bioinformatics Blood Blood cells Brain candidate Cell culture cellular Central nervous system changes in cholinergic cholinergic neurons coding transcript coding transcripts cognitive Cohort Complication Consequences COVID-19 COVID-19 infection COVID-19 pandemic Dance DANCR Decline decrease diagnostic diagnostics donors expression followed by H1N1 H1N1 influenza human lung identify increase increases in infected cell Infection Inflammation Inflammatory Influenza inter-individual involved long non-coding RNA lung lung cell lung cells lung tissue lung tissues manifestation medication men and women MicroRNAs miRNA ncRNA ncRNAs NEAT1 Neurological complications Neuron non-coding RNA nuclear parasympathetic Post-infection predicted profiles qRT-PCR Quantitative reflected risk RNA RNA-seq dataset RNA-sequencing SARS-CoV-2 selected shifting Signaling statins Supporting susceptibility TFS therapeutic tissue tissue-specific expression tissues transcript transcription factor transcription factors transcriptomic transcripts Variability viruses weakened with COVID-19 woman
[DOI] 10.3389/fimmu.2020.590870 PMC 바로가기 [Article Type] Immunology

From Influenza Virus to Novel Corona Virus (SARS-CoV-2)–The Contribution of Obesity

Endocrinology

Published on 2020-10-062022-10-31
Journal: Frontiers in Endocrinology [Category] COVID-19, MERS, SARS,

[키워드] “cytokine storm” Activation acute respiratory syndrome adipocytes Adiposity cardiovascular condition caused chronic inflammation co-morbidity Combination contribute contributing to Corona coronavirus coronavirus disease Course COVID-19 COVID-19 patients diabetes disease ectopic elevated Factor fat fatality Government H1N1 influenza health system high risk Hospitalization immune response immune system individual individuals infected individual Infection Inflammation information Lung function novel novel corona virus obese obesity pandemic Prolonged resulting SARS-CoV-2 severity the disease the SARS-CoV-2 viral infection virus
[DOI] 10.3389/fendo.2020.556962 PMC 바로가기 [Article Type] Endocrinology

A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial

Letter

Published on 2020-10-022022-10-29
Journal: Trials [Category] COVID-19, MERS, SARS,

[키워드] 1:1 Ability to communicate acute respiratory syndrome addition administration age Analysis antipyretics Arm Blinding calculated clinical clinical trial Combination common cold-like symptom control group coronavirus cough COVID-19 COVID-19 patient criteria decrease defined Dementia difficulty dissemination effective Efficacy element exclusion criteria fatigue female Fever Follow-up group H1N1 influenza hospitals Hypothesis IMPROVE in both group include Inclusion Infection Inpatient Japan Japanese Kampo Kampo medicines lactating less malaise Medicine Mild-to-moderate number objective occurred outcome Outpatient parallel-group participant Patient patients positive Prevention for severe stage previous study protocol Psychiatric random Randomized Randomized controlled trial receive recruited registry required Research Sample size SARS-CoV-2 Severe infection Severity of disease Shortness of breath significance level significantly sputum Stage steroid Study protocol survival survival curve Symptom Symptom relief symptomatic temperature the Kaplan-Meier method the log-rank test the median the primary endpoint the SARS-CoV-2 to define treated Treatment Two-arm website
[DOI] 10.1186/s13063-020-04746-9 PMC 바로가기 [Article Type] Letter